SHC Sotera Health Company

NASDAQ
$18.37

Sotera Health Company (SHC) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with SHC's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
18 transactions
Purchases
$0
0 shares
Sales
$2.6B
166,905,720 shares
Net activity
-$2.6B
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $2.6B 18 transactions · 166,905,720 shares

Largest single sale: $289.8M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Petras Michael B. Jr. 2 fills Executive Chairman Sell 1,144,515 $18.50 $21.2M 3,969,393 −22.4% of holding
Rutz Michael P President of Sterigenics Sell 150,000 $18.84 $2.8M 334,279 −31% of holding
3 fills Sell 50,941,205 $15.17 $772.7M None left
3 fills Sell 40,000,000 $15.27 $610.8M 19,102,952 −67.7% of holding
Petras Michael B. Jr. 3 fills Chairman & CEO Sell 750,000 $16.45 $12.3M 4,819,393 −13.5% of holding
3 fills Sell 25,920,000 $16.33 $423.3M 34,102,952 −43.2% of holding
3 fills Sell 48,000,000 $15.65 $751.2M 43,822,952 −52.3% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.